Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety

This study has been completed.
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by:
Rutgers, The State University of New Jersey
ClinicalTrials.gov Identifier:
NCT00177008
First received: September 13, 2005
Last updated: January 25, 2007
Last verified: January 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2007
  Estimated Primary Completion Date: No date given